| Literature DB >> 6132037 |
Abstract
A male infant with reticular dysgenesis received a bone-marrow transplant from his HLA-identical brother. Severe graft-versus-host disease developed but he responded to high-dose methylprednisolone. 3 years after grafting, the child is thriving with full haematological reconstitution and normal cell-mediated and humoral immunity. This is the first report of the survival beyond 17 weeks of a child with reticular dysgenesis.Entities:
Mesh:
Year: 1983 PMID: 6132037 DOI: 10.1016/s0140-6736(83)91968-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321